[Is the treatment of left ventricular systolic dysfunction different according to the etiology?].
Cardiac failure is the terminal stage of evolution, the finality of many valvular, vascular, myocardial, general, congenital or acquired conditions. The therapeutic decisions should be based on the search for a curable cause of a predisposing factor and the evaluation of the severity of the cardiac failure. At advanced stages of ventricular dysfunction when the myocardial lesions are constituted, when cardiac and vascular remodelling has occurred, the aetiological treatment, which is the constant objective, is unfortunately too late. The treatment is the same, whatever the aetiology, in order to improve functional problems. At early stages, and, if possible, preventively, surgery, revascularisation techniques, the correction of an arrhythmia, the suppression of a cardiotoxic factor, are essential. The different therapeutic classes used could have different efficacies depending on the aetiology, but, finally, this point is negligible: the medications are based on the results of large scale, controlled, therapeutic trials.
Bounhoure
J P
JP
Service de cardiologie, hôpital Rangueil, Toulouse.
D013504:Cardiovascular Surgical Procedures; D003657:Decision Making; D004358:Drug Therapy; D006333:Heart Failure / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D010347:Patient Care Planning; D018487:Ventricular Dysfunction, Left / Q000209:etiology* / Q000628:therapy*; D020257:Ventricular Remodeling
Le traitement de l'insuffisance cardiaque avec altération de la fonction systolique est-il différent selon l'étiologie?